Map Pharma (MAPP) Shares Now Down 30%
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Join SI Premium – FREE
After an initial move slightly lower, shares of Map Pharma (Nasdaq: MAPP) are now down more than 30 percent in Tuesday's pre-open session. The last traded was at $11.50.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scorpion Capital says short Twist Biosciences
- Lyntris opens at $15.50, below IPO price of $17.50
- Ck Hutch Seeks Over $1.5b For Destruction Of Panama Investments - Bloomberg
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
